← Leaderboards
James Raschko
University Of Southern California
$191,317
Attributed
$191,317
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$191,317 · 1
By mechanism
M01$191,317 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Heinz Josef Lenz$20,123,312
- John A Zaia$8,207,353
- Ite A Laird-Offringa$7,799,915
- Amrita Krishnan$301,778
- Christy Russell$719,837
Others in their field
Top investigators on “Adult Human (21+)”
- Tracey Devoir · Booz Allen Hamilton, Inc.$49,200,509
- James Ter Maat · Social And Scientific Systems, Inc.$49,025,547
- Lloyd D Johnston · University Of Michigan At Ann Arbor$32,327,873
- Alexa Fraser · National Opinion Research Center$26,867,847
- Taha E Taha · Johns Hopkins University$26,436,390
- Rajni Samavedam · Booz Allen Hamilton, Inc.$19,497,699
Research focus
Adult Human (21+)Breast NeoplasmsCis Platinum CompoundClinical ResearchClinical Trial Phase IColony Stimulating FactorCombination Cancer TherapyCombination ChemotherapyCyclophosphamideEtoposideEwing'S TumorGastrointestinal NeoplasmsHematopoietic Stem CellsHematopoietic Tissue TransplantationHomologous TransplantationHuman SubjectHuman Therapy EvaluationIfosfamideMelanomaNeoplasm /Cancer ChemotherapyNeoplasm /Cancer ImmunotherapyOsteosarcomaOvary NeoplasmsPaclitaxel
Grant awards (5)
SEQUENTIAL CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE &IFOSFAM$0
M01 · FY2002 · RR
SEQUENTIAL CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE &IFOSFAM$155,764
M01 · FY2001 · RR
SEQUENTIAL CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE &IFOSFAM$0
M01 · FY2001 · RR
SEQUENTIAL CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE &IFOSFAM$35,553
M01 · FY2000 · RR
SEQUENTIAL CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE &IFOSFAM$0
M01 · FY2000 · RR